Daily dose of corticosteroid
At the end of the primary treatment period, all 5 patients with NNS/CANDLE reported corticosteroid use at baseline and showed a mean decrease of 23.5% in systemic corticosteroid use with a mean change of -0.04 mg/kg/day from baseline. One patient with SAVI reported corticosteroid use at baseline and showed a clinically significant mean percent decrease of 61.2% in corticosteroid use and a mean change of -0.24 mg/kg/day from baseline (Table Corticosteroid use in patients with (At the end of the maintenance period, patients with NNS/CANDLE showed a mean percent decrease of 18.4% in systemic corticosteroids use with a mean change of -0.03 mg/kg/day from baseline. The patient with SAVI showed a clinically significant mean percent decrease of 62.9% in systemic corticosteroids use and a mean change of -0.24 mg/kg/day from baseline (Table 